James Vogel

Director and Founder at The BioProcess Institute

Speaker

Jim Vogel is a recognized subject matter expert in bioprocessing and biotechnology, with more than 36 years of experience in the biopharmaceutical, food and cosmetic industries. Mr. Vogel’s passion for the industry took root during his college years and the expertise and experience he has acquired in the interim have shaped his balanced approach to testing, training, and consulting.

He has worked as a Director, Project Manager, and Engineer (Plant Support, Process Development, Project and Automation) with Amgen, GlaxoSmithKline, ImClone, Sanofi-Pasteur, Lipton and Avon. As lead designer for a $700 million, large scale biopharmaceutical plant, he directed numerous facility renovations including upgrades to the buildings, process equipment, utilities, and laboratories.

His consulting expertise lies in all areas and all levels of engineering, management, and cGMP, including single-use applications. Jim has troubleshot plant operations for both process and utilities and has helped with organizational structures and staff development. One key area of his expertise is performing risk assessments for both operational and engineering systems.

Mr. Vogel is an adjunct professor at the University of Rhode Island, has served as URI’s former Director of the Pharmaceutical Development Institute, and as an Adjunct Professor at Stevens Institute of Technology. He is a member of the American Society of Mechanical Engineers BioProcess Equipment (ASME-BPE) Standard Committee, a former Chairman of the ASME-BPE Sealing Components Subcommittee, and a current member of ASTM, BPSA, NAHAD, ISPE and the PDA.

He is a licensed professional engineer in NJ, has a Masters of Engineering in Chemical Engineering from Manhattan College, and a Bachelor’s of Science in BioChemical Engineering from Rutgers University.

In 2007, Jim founded The BioProcess Institute to satisfy the bioprocessing industry’s need for expert testing, training and consulting all in one place as well as to combine his experience with suppliers and end users in order to benefit both. You can find Jim Vogel on LinkedIn or visit The BioProcess Institute at www.bioprocessinstitute.com.

The BioProcess Institute works with suppliers and end users worldwide to help the biopharmaceutical industry make better drugs. In addition, The BioProcess Institute is also engaged with organizations whose experts spearhead the creation and maintenance of the standards used in biopharmaceutical processing. The BioProcess Institute’s goal is to help the industry make better drugs.